Skip to Main Content

Paper Details

Validation of a Transcriptome-Based Assay for Classifying Cancers of Unknown Primary Origin.
Mol Diagn Ther
6
2023
CUP, Cancer, Cancers, Cancers of Unknown, RNA, Tempus, cancer, cancer of unknown primary, cancers, hematopoietic cells, patient, patients

Datasets

Release 1.2